SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience.

Szczegóły
Abstrakt

Tytuł:: SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience.
Autorzy:: Furfaro F; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Vuitton L; Department of Gastroenterology, Besançon University Hospital, Bourgogne-Franche-Comté University, Besançon, France.
Fiorino G; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Koch S; Department of Gastroenterology, Besançon University Hospital, Bourgogne-Franche-Comté University, Besançon, France.
Allocca M; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Gilardi D; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Zilli A; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
D'Amico F; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Radice S; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
Chevaux JB; Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Schaefer M; Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Chaussade S; Department of Gastroenterology, Paris Cochin University Hospital APHP, Paris 5 University, Besançon, France.
Danese S; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Peyrin-Biroulet L; Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France. .
Źródło:: Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2020 Aug; Vol. 17 (8), pp. 507-516. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Original Publication: London ; New York : Nature Pub. Group, c2009-
MeSH Terms:: Endoscopy, Gastrointestinal*
Coronavirus Infections/*epidemiology
Coronavirus Infections/*prevention & control
Infectious Disease Transmission, Patient-to-Professional/*prevention & control
Inflammatory Bowel Diseases/*diagnosis
Inflammatory Bowel Diseases/*therapy
Pandemics/*prevention & control
Pneumonia, Viral/*epidemiology
Pneumonia, Viral/*prevention & control
Betacoronavirus ; COVID-19 ; Decision Making ; France/epidemiology ; Humans ; Italy/epidemiology ; Patient Selection ; Personal Protective Equipment ; SARS-CoV-2
References:: In Vivo. 2020 Mar-Apr;34(2):723-728. (PMID: 32111776)
Gut. 2020 Aug;69(8):1543-1544. (PMID: 32312790)
Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427. (PMID: 32171057)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570)
J Crohns Colitis. 2020 Sep 16;14(9):1330-1333. (PMID: 32211765)
Am J Gastroenterol. 2015 Sep;110(9):1324-38. (PMID: 26303131)
Lancet. 2018 Dec 23;390(10114):2779-2789. (PMID: 29096949)
J Hosp Infect. 2020 Mar;104(3):246-251. (PMID: 32035997)
J Crohns Colitis. 2015 Nov;9(11):945-65. (PMID: 26294789)
J Crohns Colitis. 2019 Feb 1;13(2):144-164. (PMID: 30137275)
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606. (PMID: 32305075)
J Crohns Colitis. 2020 Sep 7;14(8):1162-1171. (PMID: 32103246)
Mod Pathol. 2018 Mar;31(3):527-538. (PMID: 29192648)
Gastroenterology. 2020 May;158(6):1831-1833.e3. (PMID: 32142773)
Gut. 2020 Sep;69(9):1629-1636. (PMID: 31862811)
Inflamm Bowel Dis. 2010 Sep;16(9):1620-7. (PMID: 20232408)
Dig Endosc. 2020 Jul;32(5):715-722. (PMID: 32281689)
PLoS One. 2019 Apr 18;14(4):e0214751. (PMID: 30998692)
Endoscopy. 2020 Jun;52(6):483-490. (PMID: 32303090)
Eur Heart J Cardiovasc Imaging. 2020 Jun 1;21(6):592-598. (PMID: 32242891)
Dig Dis Sci. 2015 Nov;60(11):3203-8. (PMID: 26031424)
J Crohns Colitis. 2018 Mar 28;12(4):432-441. (PMID: 29228230)
Gut. 1996 Jun;38(6):905-10. (PMID: 8984031)
Gut. 2020 Jun;69(6):1002-1009. (PMID: 32213556)
J Clin Med. 2019 Dec 08;8(12):. (PMID: 31817972)
Gut. 2020 Jun;69(6):984-990. (PMID: 32303607)
JAMA. 2019 Sep 3;322(9):824-833. (PMID: 31479137)
Aliment Pharmacol Ther. 2020 Apr;51(7):689-698. (PMID: 32048751)
Nature. 2020 May;581(7809):465-469. (PMID: 32235945)
J Dig Dis. 2020 Mar;21(3):125-126. (PMID: 32096611)
J Crohns Colitis. 2017 Jun 1;11(6):649-670. (PMID: 28158501)
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. (PMID: 32141570)
Nat Med. 2020 May;26(5):676-680. (PMID: 32371934)
Clin Gastroenterol Hepatol. 2020 May;18(6):1309-1323.e4. (PMID: 31812657)
J Crohns Colitis. 2016 Aug;10(8):873-85. (PMID: 26928961)
Gut. 2020 Jun;69(6):991-996. (PMID: 32241897)
J Crohns Colitis. 2020 Sep 7;14(8):1037-1048. (PMID: 32032423)
Gastroenterology. 2020 May;158(6):1518-1519. (PMID: 32142785)
J Crohns Colitis. 2019 Apr 26;13(5):555-563. (PMID: 30476099)
Nat Microbiol. 2020 Apr;5(4):536-544. (PMID: 32123347)
Nat Rev Microbiol. 2019 Mar;17(3):181-192. (PMID: 30531947)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Gastroenterology. 2020 Aug;159(2):739-758.e4. (PMID: 32247018)
Br Med J. 1955 Oct 29;2(4947):1041-8. (PMID: 13260656)
Aliment Pharmacol Ther. 2020 May;51(9):843-851. (PMID: 32222988)
Am J Gastroenterol. 2020 May;115(5):766-773. (PMID: 32287140)
JAMA. 2020 Apr 28;323(16):1610-1612. (PMID: 32129805)
Gastroenterology. 2017 Jan;152(1):271-275. (PMID: 27840074)
N Engl J Med. 2020 Apr 16;382(16):1564-1567. (PMID: 32182409)
Inflamm Bowel Dis. 2017 Sep;23(9):1600-1604. (PMID: 28590341)
JAMA. 2020 May 12;323(18):1843-1844. (PMID: 32159775)
Gut. 2018 Sep;67(9):1626-1636. (PMID: 29777042)
Science. 2020 Jul 3;369(6499):50-54. (PMID: 32358202)
Gut. 2019 Apr;68(4):615-622. (PMID: 29720408)
Scand J Gastroenterol. 2019 Jul;54(7):849-854. (PMID: 31264494)
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1663-1672. (PMID: 32278065)
Entry Date(s):: Date Created: 20200613 Date Completed: 20200805 Latest Revision: 20220716
Update Code:: 20240104
PubMed Central ID:: PMC7288265
DOI:: 10.1038/s41575-020-0319-3
PMID:: 32528139
: Czasopismo naukowe

The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has required a complete change in the management of patients with inflammatory bowel disease (IBD) who need to undergo endoscopic procedures. Several preventive measures must be taken to avoid the spread of infection among health-care professionals and patients with IBD, including the use of personal protective equipment, greater attention to endoscopic room hygiene and rescheduling of non-urgent procedures. This Perspective aims to provide a guide based on the Italian and French experience to better face the difficulties encountered by endoscopists during this global health emergency. In particular, recommendations regarding the use of personal protective equipment to prevent COVID-19 transmission, both for patients and health-care professionals, are proposed and different scenarios in endoscopic IBD management are evaluated to suggest when endoscopy could be rescheduled and replaced by alternative biomarkers.

Informacja